Two-Year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease

Study 018 Investigators

Research output: Contribution to journalArticle

113 Citations (Scopus)

Fingerprint Dive into the research topics of 'Two-Year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences